SEM/EDS analysis as a complementary tool for continuous improvement of cefixime granules for oral suspension
References
- International Council for Harmonisation, ICH Harmonised Guideline Q8(R2): Pharmaceutical Development, Current Step 4 version, August 2009; https://database.ich.org/sites/default/files/Q8_R2_Guideline.pdf; last access date May 27, 2026.
- International Council for Harmonisation, ICH Harmonised Guideline Q9(R1): Quality Risk Management, Current Step 4 version, 18 January 2023; https://database.ich.org/sites/default/files/ICH_Q9%28R1%29_Guideline_Step4_2022_1219.pdf; last access date May 27, 2026.
- International Council for Harmonisation, ICH Harmonised Tripartite Guideline Q10: Pharmaceutical Quality System, Current Step 4 version, 4 June 2008; https://database.ich.org/sites/default/files/Q10%20Guideline.pdf; last access date May 27, 2026.
- Food and Drug Administration, Process Validation: General Principles and Practices, Guidance for Industry, January 2011; https://www.fda.gov/files/drugs/published/Process-Validation-General-Principles-and-Practices.pdf; last access date May 27, 2026.
- Food and Drug Administration, PAT – A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance, Guidance for Industry, September 2004; https://www.fda.gov/media/71012/download; last access date May 27, 2026.
- International Council for Harmonisation, ICH Harmonised Guideline Q14: Analytical Procedure Development, Final version, adopted on 1 November 2023; https://database.ich.org/sites/default/files/ICH_Q14_Guideline_2023_1116_1.pdf; last access date May 27, 2026.
- International Council for Harmonisation, ICH Harmonised Tripartite Guideline Q1A(R2): Stability Testing of New Drug Substances and Products, Current Step 4 version, 6 February 2003; https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf; last access date May 27, 2026.
- S. M. Iveson, J. D. Litster, K. Hapgood and B. J. Ennis, Nucleation, growth and breakage phenomena in agitated wet granulation processes: A review, Powder Technol. 117(1–2) (2001) 3–39; https://doi.org/10.1016/S0032-5910(01)00313-8
- J. D. Litster and B. J. Ennis, The Science and Engineering of Granulation Processes, Kluwer Academic Publishers, Dordrecht 2004; https://doi.org/10.1007/978-94-017-0546-2
- D. M. Parikh (Ed.), Handbook of Pharmaceutical Granulation Technology, 3rd ed., CRC Press, Boca Raton 2016; https://doi.org/10.3109/9781616310035
- M. E. Aulton and K. M. G. Taylor (Eds.), Aulton’s Pharmaceutics: The Design and Manufacture of Medicines, 5th ed., Elsevier, Edinburgh 2018.
- P. J. Sheskey, W. G. Cook and C. G. Cable (Eds.), Handbook of Pharmaceutical Excipients, 9th ed., Pharmaceutical Press, London 2020.
- H. G. Brittain (Ed.), Physical Characterization of Pharmaceutical Solids, Marcel Dekker, New York 1995.
- S. R. Byrn, R. R. Pfeiffer and J. G. Stowell, Solid-State Chemistry of Drugs, 2nd ed., SSCI, West Lafayette 1999.
- B. C. Hancock and G. Zografi, Characteristics and significance of the amorphous state in pharmaceutical systems, J. Pharm. Sci. 86(1) (1997) 1–12; https://doi.org/10.1021/js9601896
- J. I. Goldstein, D. E. Newbury, J. R. Michael, N. W. M. Ritchie, J. H. J. Scott and D. C. Joy, Scanning Electron Microscopy and X-ray Microanalysis, 4th ed., Springer, New York 2018; https://doi.org/10.1007/978-1-4939-6676-9
- P. J. Goodhew, J. Humphreys and R. Beanland, Electron Microscopy and Analysis, 3rd ed., Taylor & Francis, London 2000; https://doi.org/10.1201/9781482289343
- P. Echlin, Handbook of Sample Preparation for Scanning Electron Microscopy and X-ray Microanalysis, Springer, New York 2009; https://doi.org/10.1007/978-0-387-85731-2
- D. E. Newbury and N. W. M. Ritchie, Is scanning electron microscopy/energy dispersive X-ray spectrometry (SEM/EDS) quantitative?, Scanning 35(3) (2013) 141–168; https://doi.org/10.1002/sca.21041
- D. E. Newbury and N. W. M. Ritchie, Electron-excited X-ray microanalysis by energy dispersive spectrometry at 50: Analytical accuracy, precision, trace sensitivity, and quantitative compositional mapping, Microsc. Microanal. 25(5) (2019) 1075–1105; https://doi.org/10.1017/S143192761901482X
- R. N. Brogden and D. M. Campoli-Richards, Cefixime: A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential, Drugs 38(4) (1989) 524–550; https://doi.org/10.2165/00003495-198938040-00004
- S. R. El-Shaboury, G. A. Saleh, F. A. Mohamed and A. H. Rageh, Analysis of cephalosporin antibiotics, J. Pharm. Biomed. Anal. 45(1) (2007) 1–19; https://doi.org/10.1016/j.jpba.2007.06.002
- A. D. Deshpande, K. G. Baheti and N. R. Chatterjee, Degradation of β-lactam antibiotics, Curr. Sci. 87(12) (2004) 1684–1695.
- K. C. Waterman and R. C. Adami, Accelerated aging: Prediction of chemical stability of pharmaceuticals, Int. J. Pharm. 293(1–2) (2005) 101–125; https://doi.org/10.1016/j.ijpharm.2004.12.013
- Z. Talebpour, H. Pourabdollahi, H. Rafati, A. Abdollahpour, Y. Bashour and H. Y. Aboul-Enein, Determination of cefixime by a validated stability-indicating HPLC method and identification of its related substances by LC-MS/MS studies, Sci. Pharm. 81(2) (2013) 493–503; https://doi.org/10.3797/scipharm.1301-15
- S. P. Gandhi and S. J. Rajput, Study of degradation profile and development of stability indicating methods for cefixime trihydrate, Indian J. Pharm. Sci. 71(4) (2009) 438–442; https://doi.org/10.4103/0250-474X.57295
- S. Yu, Y. Zhang and X. Z. Wang, Improved understanding of cefixime trihydrate reactive crystallization and process scale-up with the aid of PAT, Org. Process Res. Dev. 23(2) (2019) 177–188; https://doi.org/10.1021/acs.oprd.8b00190
- Y. Roggo, P. Chalus, L. Maurer, C. Lema-Martinez, A. Edmond and N. Jent, A review of near infrared spectroscopy and chemometrics in pharmaceutical technologies, J. Pharm. Biomed. Anal. 44(3) (2007) 683–700; https://doi.org/10.1016/j.jpba.2007.03.023
- G. Reich, Near-infrared spectroscopy and imaging: Basic principles and pharmaceutical applications, Adv. Drug Deliv. Rev. 57(8) (2005) 1109–1143; https://doi.org/10.1016/j.addr.2005.01.020
- T. Vankeirsbilck, A. Vercauteren, W. Baeyens, G. Van der Weken, F. Verpoort, G. Vergote and J. P. Remon, Applications of Raman spectroscopy in pharmaceutical analysis, TrAC Trends Anal. Chem. 21(12) (2002) 869–877; https://doi.org/10.1016/S0165-9936(02)01208-6
Language: English
Page range: 1 - 11
Accepted on: Jun 10, 2026
Published on: Jun 30, 2026
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Ivana Mitrevska, Dino Karpicarov, Ana Mihailovska, Dejan Mirakovski, Olivera Paneva, Gjorgji Petrushevski, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.